Cerity Partners
YDESW

Cerity Partners’s YD Bio Ltd Warrants YDESW Stock Holding History

Cerity Partners’s Portfolio YDESW Stock Details YDESW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$208K Hold
320,089
– – ﹤0.01% 2862
2025
Q4 		$317K Buy
320,089
+8,500
+3% +$12K ﹤0.01% 2375
2025
Q3 		$664K Buy
+311,589
New +$544K ﹤0.01% 1807

Other funds holding YDESW

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $877M AUM 13.86% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $9.2B AUM 23.26% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return

Cerity Partners's YDESW Position: Q1 2026 in Review

Cerity Partners held its YD Bio Ltd Warrants (YDESW) position steady in Q1 2026 at 320,089 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #2862.

Cerity Partners first reported a position in YDESW in Q3 2025 and has held it in 3 quarters since. The position peaked at $664K in Q3 2025. 9 funds tracked by Wall St. Rank hold YDESW as of Q1 2026.

  • Cerity Partners held 320,089 shares of YD Bio Ltd Warrants worth $208K as of Q1 2026.
  • Cerity Partners left its YD Bio Ltd Warrants share count unchanged in Q1 2026.
  • YD Bio Ltd Warrants made up ﹤0.01% of Cerity Partners's portfolio in Q1 2026, its #2862 holding.
  • Cerity Partners first reported a position in YD Bio Ltd Warrants in Q3 2025 and has held it in 3 quarters since.
  • Cerity Partners's YD Bio Ltd Warrants position peaked at $664K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held YD Bio Ltd Warrants as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.